C

Celldex Therapeutics

Develops antibody-based therapies targeting inflammatory diseases

Vice President, Corporate Controller

Financial AccountingConfirmed live in the last 24 hours
Full-timeHampton, NJ, USA

About the Job

Requirements

  • A bachelor's degree in Accounting is required.
  • A Certified Public Accountant (CPA) credential is required.
  • At least 15 years of progressive accounting and finance experience is required.
  • At least 8 years of leadership experience, including responsibility for building and leading accounting teams, is required.
  • Public-company accounting and SEC reporting experience is required.
  • Strong experience with SOX 404 and internal control environments is required.
  • Pharmaceutical, biotechnology, or life sciences industry experience is required.
  • Commercial biopharmaceutical accounting experience is required.

Responsibilities

  • Lead all accounting operations and monthly, quarterly, and annual close processes.
  • Ensure timely and accurate financial reporting in accordance with U.S. GAAP.
  • Maintain and continuously strengthen accounting policies, procedures, and internal controls.
  • Oversee the general ledger, consolidation, reconciliations, and related accounting processes.
  • Drive continuous improvement and efficiency across the close process.
  • Ensure the accounting organization and infrastructure can support the transition from pre-commercial to commercial operations.
  • Build scalable capabilities to support multiple commercial products, multiple development-stage assets, organizational and geographic expansion, business development activities, and M&A integration.
  • Provide executive oversight for commercial accounting, including revenue recognition under ASC 606, product sales and specialty pharmacy and distribution accounting, gross-to-net accounting and reserve processes, chargebacks, commercial and government rebates, product returns, distribution fees, patient assistance and copay programs, and government programs such as Medicaid and 340B.
  • Ensure gross-to-net reserves and methodologies are accurate, defensible, appropriately controlled, and well documented.
  • Partner with Commercial Finance, Market Access, Government Pricing, Trade & Distribution, FP&A, and other business stakeholders on accurate financial reporting and launch readiness.
  • Lead accounting activities supporting manufacturing, supply chain, and commercial distribution, including inventory and cost accounting, CDMO manufacturing relationships, contract packaging organizations, third-party logistics providers, finished goods, raw materials and work-in-process inventory, standard costing, inventory reserves and obsolescence, cost of goods sold, and inventory capitalization and controls.
  • Establish scalable inventory and costing processes for commercialization and future growth.
  • Provide technical accounting guidance for complex business development transactions, asset acquisitions, licensing arrangements, collaboration agreements, milestone payments, royalties, M&A transactions, impairments, equity compensation, and debt and financing arrangements.
  • Prepare or oversee accounting position papers, technical accounting memoranda, and supporting documentation for auditors and management.
  • Oversee accounting activities for clinical development and research, including clinical trial accruals, CRO accounting, investigator and site payments, clinical and development obligations, collaboration and co-development agreements, licensing arrangements, milestones and royalties, and development-stage manufacturing accounting.
  • Oversee shared accounting operations supporting Accounts Payable, Payroll, Equity Administration, and related corporate accounting activities.
  • Lead and strengthen the SOX and internal control environment, including risk assessments, control design, process documentation, control testing oversight, deficiency identification and remediation, segregation of duties, and audit coordination and support.
  • Build a sustainable internal control framework for a larger, more complex commercial-stage organization.
  • Partner with Finance, IT, Commercial Operations, and other business functions to develop scalable financial infrastructure and systems.
  • Provide accounting leadership and requirements for ERP, revenue management, gross-to-net, inventory and supply chain, consolidation, financial reporting, and analytics platforms.
  • Lead and support future system implementations, automation, and process transformation initiatives.
  • Build, lead, and develop a high-performing accounting organization.
  • Establish an organizational structure to support commercial growth and increasing complexity.
  • Recruit and develop accounting and finance talent.
  • Establish performance expectations, development plans, and succession strategies.
  • Foster accountability, partnership, accuracy, and continuous improvement.
  • Serve as a trusted advisor and business partner to Finance leadership and the broader organization.

Desired Qualifications

  • Experience supporting a pharmaceutical or biotechnology product launch is strongly preferred.
  • Experience scaling an accounting organization from pre-commercial through commercial stage is strongly preferred.
  • Public accounting experience is preferred.
  • An MBA or advanced degree is preferred.

About the Company

Celldex Therapeutics

Develops antibody-based therapies targeting inflammatory diseases

Celldex Therapeutics develops antibody-based therapies for inflammatory, allergic, and autoimmune diseases, focusing on mast cell biology. Its lead program barzolvolimab is a humanized monoclonal antibody that inhibits KIT, reducing mast cell activity and inflammation; its pipeline includes other antibodies designed to engage the immune system or modulate disease pathways. The company leverages partnerships and licensing in addition to developing its own therapies to create a breadth of programs in its target areas. Its goal is to deliver therapies that lessen inflammation and autoimmune activity by targeting mast cells and related signaling pathways.

Company size
201-500
Company stage
IPO
Headquarters
Hampton, NJ
Founded
1983

Recently Posted Jobs

Explore more opportunities at Celldex Therapeutics

See more jobs